Literature DB >> 10760807

A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains.

C A van Els1, C A Herberts, E van der Heeft, M C Poelen, J A van Gaans-van den Brink, A van der Kooi, P Hoogerhout, G Jan ten Hove, H D Meiring, A P de Jong.   

Abstract

We studied the natural MHC class I display of measles virus (MV) epitopes. Peptide ligands associated with HLA-A*0201 were purified from a B lymphoblastoid cell line prior to and after infection with MV. Infection-induced peptides were revealed using microcapillary reversed phase high performance liquid chromatography electrospray ionization/mass spectrometry (microLC-ESI/MS) by subtraction of the "infected" and "uninfected" ion traces. Three naturally processed viral epitopes derived from different MV proteins were identified through tandem MS sequencing. These peptides were expressed at widely divergent levels of HLA-peptide complexes, but had similar binding capacities to HLA-A*0201. The most abundant viral peptide species, identified as residues 84-92 (KLWESPQEI) of the MV nonstructural C protein, was expressed at an unprecedented high density (> 10(5) copies per cell) and was immunogenic in HLA-A2/Kb-transgenic mice. Furthermore, natural mutants of this epitope, occurring in persistent lethal MV strains, were shown to have lost their HLA-A*0201 binding capacity. Thus, here we report for the first time the direct discovery through microLC-ESI/MS of a uniquely dominant viral HLA class I ligand, KLWESPQEI, with features eligible for immune selection pressure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760807     DOI: 10.1002/(SICI)1521-4141(200004)30:4<1172::AID-IMMU1172>3.0.CO;2-J

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

2.  The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.

Authors:  Victor H Engelhard
Journal:  Int J Mass Spectrom       Date:  2007-01-01       Impact factor: 1.986

3.  Peptide antagonism as a mechanism for NK cell activation.

Authors:  Lena Fadda; Gwenoline Borhis; Parvin Ahmed; Kuldeep Cheent; Sophie V Pageon; Angelica Cazaly; Stavros Stathopoulos; Derek Middleton; Arend Mulder; Frans H J Claas; Tim Elliott; Daniel M Davis; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

4.  Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD).

Authors:  Geert P M Mommen; Christian K Frese; Hugo D Meiring; Jacqueline van Gaans-van den Brink; Ad P J M de Jong; Cécile A C M van Els; Albert J R Heck
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

5.  Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-12-06       Impact factor: 2.846

6.  Induction of CD4 T cell proliferation and in vitro Th1-like cytokine responses to measles virus.

Authors:  R C Howe; N Dhiman; I G Ovsyannikova; G A Poland
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 7.  MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines.

Authors:  Joseph D Comber; Ramila Philip
Journal:  Ther Adv Vaccines       Date:  2014-05

8.  Vigorous but short-term gamma interferon T-cell responses against a dominant HLA-A*02-restricted measles virus epitope in patients with measles.

Authors:  Assan Jaye; Carla A Herberts; Sabelle Jallow; Sowsan Atabani; Michel R Klein; Peter Hoogerhout; Michael Kidd; Cécile A C M van Els; Hilton C Whittle
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.

Authors:  Zaza M Ndhlovu; Monika Angenendt; Diana Heckel; Jonathan P Schneck; Diane E Griffin; Mathias Oelke
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

10.  Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.

Authors:  Inna G Ovsyannikova; Kenneth L Johnson; David C Muddiman; Robert A Vierkant; Gregory A Poland
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.